New Evidence Links Labetalol and High-Dose Atorvastatin to Rare Liver Injury
A systematic review found strong FAERS signals linking labetalol to rare liver injury, while a case report describes hyperacute liver failure from high-dose atorvastatin that resolved after discontinuation.